Qube Research & Technologies »

Bio-path Hldgs shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Bio-path Hldgs (BPTH) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Bio-path Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Bio-path Hldgs held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-path Hldgs by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $200 100 2.00

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Visa Com Cl A (V)
Microsoft Corporation (MSFT)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Merck & Co (MRK)
Accenture Plc Ireland Shs Class A (ACN)
Lam Research Corporation (LRCX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amgen (AMGN)
Adobe Systems Incorporated (ADBE)
NVIDIA Corporation (NVDA)

View all positions for Qube Research & Technologies

Top funds holding Bio-path Hldgs

Armistice Capital
Hrt Financial
Vanguard Group
Geode Capital Management
Tower Research Capital
BlackRock
UBS Group
Qube Research & Technologies
Bank of America Corporation
Morgan Stanley
Group One Trading
Global Retirement Partners
Hanson McClain Advisors

View all funds holding Bio-path Hldgs